NDC Package 59310-610-31 Cinqair

Reslizumab Injection, Solution, Concentrate Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
59310-610-31
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-USE
Product Code:
Proprietary Name:
Cinqair
Non-Proprietary Name:
Reslizumab
Substance Name:
Reslizumab
Usage Information:
This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Reslizumab belongs to a class of drugs known as monoclonal antibodies. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed.
11-Digit NDC Billing Format:
59310061031
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1746893 - reslizumab 100 MG in 10 ML Injection
  • RxCUI: 1746893 - 10 ML reslizumab 10 MG/ML Injection
  • RxCUI: 1746893 - reslizumab 100 MG per 10 ML Injection
  • RxCUI: 1746898 - CINQAIR 100 MG in 10 ML Injection
  • RxCUI: 1746898 - 10 ML reslizumab 10 MG/ML Injection [Cinqair]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Respiratory, Llc
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA761033
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    04-18-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 59310-610-31 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    59310061031J2786Injection, reslizumab, 1mg1 MG101100100

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    59310-610-331 VIAL, SINGLE-USE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-USE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 59310-610-31?

    The NDC Packaged Code 59310-610-31 is assigned to a package of 1 vial, single-use in 1 carton / 10 ml in 1 vial, single-use of Cinqair, a human prescription drug labeled by Teva Respiratory, Llc. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 59310-610 included in the NDC Directory?

    Yes, Cinqair with product code 59310-610 is active and included in the NDC Directory. The product was first marketed by Teva Respiratory, Llc on April 18, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 59310-610-31?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 59310-610-31?

    The 11-digit format is 59310061031. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-259310-610-315-4-259310-0610-31